Skip to Content
Stock Analyst Update

Market Overly Optimistic About PotashCorp/Agrium Merger

If the deal goes through, we would expect to award the combined company a narrow moat rating, based on cost advantages in potash for both PotashCorp and Agrium, and Agrium's solid cost position in nitrogen.

Mentioned: ,

 Agrium (AGU) has confirmed that it is in discussions with  Potash Corp (POT) regarding a potential "merger of equals." News reports say a deal could be agreed upon as early as next week. Without the disclosure of merger terms, we're sticking with our current fair value estimates for now--PotashCorp at $20 per share (CAD 26) and Agrium at $96 per share (CAD 125). But we would likely adjust our fair value estimates upward if a deal is agreed upon, based primarily on cost synergies, with less impact from firmer potash pricing.

At first glance, we think the market's positive response (POT up 10% and AGU up 6%) to the deal looks a bit optimistic. In addition to cost synergies, the market is likely baking in improved industry fundamentals from the deal, most likely better potash pricing. For example, potash and phosphate peer Mosaic, a company not part of the proposed deal, is up more than 9% as we write. We think the likelihood of higher potash prices directly related to the deal is limited as Agrium is a second-tier player in the global potash market. Agrium controls roughly 2 million metric tons of the 60 million metric ton market and already co-markets its potash sales outside of North America with PotashCorp and Mosaic.

If the parties agree to a deal, our base case assumption would likely be that regulators would allow the deal to proceed, given fertilizer markets would remain very competitive for the highly commoditized fertilizer products sold by the two companies. On the moat side, we would expect to award the combined company a narrow rating, based on cost advantages in potash for both PotashCorp and Agrium, and Agrium's solid cost position in nitrogen.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Jeffrey Stafford does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.